Publications & Reports

Patterns and correlates of cannabidiol product and marijuana co-use in a sample of U.S. young adults.
Dunbar MS, Seelam R, Tucker JS, Firth CL, Pedersen ER, Klein DJ, Rodriguez A, D’Amico EJ.
Addictive Behaviors 2022;126: 107185

WA State Project to Prevent Prescription Drug/Opioid Overdose: Final Report on Naloxone Distribution, September 1, 2016 – August 31, 2021.
Seattle, WA: Addictions, Drug & Alcohol Institute (ADAI), University of Washington, November 2021.

“Your ‘give a damn’ just really stops giving a damn”: Perspectives of people who use methamphetamine on reducing or stopping their use.
Teadt S, Newman A.
Seattle, WA: Addictions, Drug & Alcohol Institute (ADAI), University of Washington, October 2021.

Cannabis sales increases during COVID-19: Findings from Alaska, Colorado, Oregon, and Washington.
Schauer GL, Dilley JA, Roehler DR, Sheehy TJ, Filley JR, Broschart SC, Holland KM, Baldwin GT, Holmes-Chavez AK, Hoots BR.
International Journal of Drug Policy 2021;98:103384.

Barriers to recruitment, retention and intervention delivery in a randomized trial among patients with firearm injuries.
Floyd AS, Lyons VH, Whiteside LK, Haggerty KP, Rivara FP, Rowhani-Rahbar A.
Injury Epidemiology 2021;8:37.

Group Counseling for People in Medication Treatment for Opioid Use Disorder
Peavy KM, Banta-Green C.
Seattle, WA: Addictions, Drug & Alcohol Institute (ADAI), University of Washington, June 2021.

Understanding and Supporting Adolescents with an Opioid Use Disorder
Peavy KM, Banta-Green C.
Seattle, WA: Addictions, Drug & Alcohol Institute (ADAI), University of Washington, June 2021.

Buprenorphine utilization among all Washington State residents’ based upon prescription monitoring program data – Characteristics associated with two measures of retention and patterns of care over time.
Banta-Green CJ, Hansen RN, Ossiander EM, Wasserman CR, Merrill JO.
Journal of Substance Abuse Treatment 2021;127:108446

Opioids and Stimulants: What Are They and How Are People Using Them?
Peavy KM, Banta-Green C, Owens M.
Seattle, WA: Addictions, Drug & Alcohol Institute (ADAI), University of Washington, April 2021.

Helping People Who Use Opioids and Stimulants.
Peavy KM, Banta-Green C, Owens M.
Seattle, WA: Addictions, Drug & Alcohol Institute (ADAI), University of Washington, April 2021.

Cannabis retail staff (“budtenders”) attitudes towards cannabis effects on health and experiences interacting with consumers – Washington State, USA.
Carlini BH, Garrett SB, Firth C, Harwick R.
Journal of Psychoactive Drugs 2021 (in press).

Neighborhood disadvantage and firearm injury: Does shooting location matter?
Dalve K, Gause E, Mills B, Floyd AS, Rivara FP, Rowhani-Rahbar A.
Injury Epidemiology 2021;8, 10.

Acute Consequences of Methamphetamine Use Among Participants of Syringe Service Programs.
Banta-Green C, Kingston S, Newman A.
Seattle, WA: Addictions, Drug & Alcohol Institute (ADAI), University of Washington, February 2021.

Interim Biennial Marijuana Research Report 2019-2021
Carlini BH, Garrett S.
Seattle, WA: ADAI, University of Washington, 2021.

Helping individuals with firearm injuries: A cluster randomized trial.
Lyons VH, Floyd AS, Griffin E, Wang J, Hajat A, Carone M, Benkeser D, Whiteside LK, Haggerty KP, Rivara FP, Rowhani-Rahbar A.
Journal of Trauma and Acute Care Surgery 2021;90(4):722-730.

Re-thinking patient stability for methadone in opioid treatment programs during a global pandemic: Provider perspectives.
Hatch-Maillette MA, Peavy KM, Tsui JI, Banta-Green CJ, Woolworth S, Grekin P.
Journal of Substance Abuse Treatment 2021;124:108223.

Is extended release naltrexone superior to buprenorphine-naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial.
Roache JD, Pavlicova M, Campbell ANC, Choo T, Peavy M, Kermack AS, Nunes EV, Rotrosen J.
Alcoholism: Clinical and Experimental Research 2021 (in press).

Establishing a new measure of alcohol-related sexual consequences and examining its association to alcohol consequences among at-risk young adults.
Fairlie AM, Jaffe AE, Davis KC, Litt DM, Kaysen D, Norris J, Lewis MA.
Journal of Studies on Alcohol and Drugs 2021;82(4):493-502.

Lessons shared: Implementation of a randomized clinical trial for alcohol use disorders with five American Indian and Alaska Native communities. 
Hirchak K, Jansen K, Lyons AJ, Bergerson D, Shaw J, Dirks LG, Avey J, Calhoun D, Jackson C, Launch L, Donovan DM, et al.
Collaborations 2021;4(1):5.

Examining associations between licensed and unlicensed outlet density and cannabis outcomes from preopening to postopening of recreational cannabis outlets.
Pedersen ER, Firth CL, Rodrigues A, et al.
American Journal on Addictions 2020;30(2):122-130.

Using digital technologies in clinical trials: Current and future applications.
Rosa C, Marsch LA, Winstanley EL, Brunner M, Campbell ANC.
Contemporary Clinical Trials 2021;100:106219.

Alcohol and substance use among first-year students at the University of Nairobi, Kenya: Prevalence and patterns.
Musyoka CM, Mbwayo A, Mathai M, Donovan DM.
PLOS One 2020;15(8):e0238170.

A taxonomy of consumers’ perspectives on the function of cannabis in their lives: A qualitative study in WA State, USA.
Harwick R, Carlini BH, Garrett SB.
Journal of Psychoactive Drugs 2020;52(5):393-400.

Risk and protective factors associated with moderate and acute suicidal ideation among a national sample of Tribal College and University students, 2015-2016.
Parker M, Duran B, Rhew I, Margarati M, Larimer M, Donovan DM.
Journal of Rural Health 2021;37(3): 545-553.

mHealth-based peer mentoring for prevention of alcohol and substance abuse among first year university students: Protocol for quasi-experimental intervention.
Musyoka C, Mbwayo A, Donovan DM, Mathai M.
Journal of Substance Use 2021;26(1):53-59.

Anytime is the right time: A content analysis of marijuana ads in freely distributed print media in Western Washington State, USA.
Carlini BH, Harwick R, Garrett S.
Substance Use & Misuse 2020;55:806-817.

Service utilization and chronic condition outcomes among primary care patients with substance use disorders and co-occurring chronic conditions.
Stephens KA, West II, Hallgren KA, Mollis B, Ma K, Donovan DM, Stuvek B, Baldwin LM.
Journal of Substance Abuse Treatment 2020;112S:49-55.

Impact of a jail-based treatment decision-making intervention on post-release initiation of medications for opioid use disorder.
Banta-Green CJ, Williams JR, Sears JM, Floyd AS, Tsui JI, Hoeft TJ.
Drug & Alcohol Dependence 2020;207:107799

Medical cannabis and opioid-related deaths: What is the evidence?
Carlini BH.
Seattle, ADAI, University of Washington, December 2018, 6 p.

Fidelity assessment of a social work-led intervention among patients with firearm injuries.
Lyons VH, Benson LR, Griffin E, Floyd AS, Kiche SW, Haggerty KP, Whiteside L, Conover S, Herman DB, Rivara FP, Rowhani-Rahbar A.
Research on Social Work Practice 2020;30(6):378-687.